The Efficacy and Safety of Task-state-based Temporal Interference Stimulation (TI) in the Treatment of Patients With Depression
Condition(s) studied
Investigational drug(s) / intervention(s)
Temporal Interference Stimulation: During the treatment period, all subjects were treated with a fixed time interference stimulation (TI) device at a frequency of 30 minutes twice a day, 5 days a week, for a total of 10 treatments. The output current intensity during treatment is 3.64 mA+4.36 mA.
Study summary
This study intends to investigate the intervention efficacy of temporal interference stimulation (TI) on mood symptoms in depressed patients, as well as to explore the neuroimaging mechanisms of TI improvement in depressed patients using pre- and post-treatment magnetic resonance.
Eligibility
Primary outcome measure(s)
- Hamilton Depression Scale(HAMD-17) — 0-5 days
The Hamilton Depression Scale(HAMD-17) was used to assess the extent of the patient's depressive episodes, with higher scores representing more severe depression, and this scale was used to monitor the patient's improvement in depression before and after treatment.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Psychiatry, First Affiliated Hospital of Zhejiang University | Hangzhou | Zhejiang |
More First Affiliated Hospital of Zhejiang University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06826469 on ClinicalTrials.gov ↗ ← All trials in China